Carriers of CYP3A4*22 and PPAR-α (rs4253728, rs4823613) variants showed a nonsignificant trend toward lower platelet aggregation (ie, higher platelet inhibition) than non-carriers ( Table 3 ).
← all excerpts
Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response.
1
—
—